Literature DB >> 19204267

Epistasis: multiple sclerosis and the major histocompatibility complex.

Sreeram V Ramagopalan1, George C Ebers.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19204267      PMCID： PMC2818182          DOI： 10.1212/01.wnl.0000341941.24967.e6

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  8 in total

1.  Genome-wide strategies for detecting multiple loci that influence complex diseases.

Authors:  Jonathan Marchini; Peter Donnelly; Lon R Cardon
Journal:  Nat Genet       Date:  2005-03-27       Impact factor: 38.330

2.  Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance.

Authors:  David A Dyment; Blanca M Herrera; M Zameel Cader; Cristen J Willer; Matthew R Lincoln; A Dessa Sadovnick; Neil Risch; George C Ebers
Journal:  Hum Mol Genet       Date:  2005-06-01       Impact factor: 6.150

3.  An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus.

Authors:  G C DeLuca; S V Ramagopalan; B M Herrera; D A Dyment; M R Lincoln; A Montpetit; M Pugliatti; M C N Barnardo; N J Risch; A D Sadovnick; M Chao; S Sotgiu; T J Hudson; G C Ebers
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-17       Impact factor: 11.205

4.  A "new" blood group character related to the ABO system.

Authors:  Y M BHENDE; C K DESHPANDE; H M BHATIA; R SANGER; R R RACE; W T J MORGAN; W M WATKINS
Journal:  Lancet       Date:  1952-05-03       Impact factor: 79.321

5.  Masking epilepsy by combining two epilepsy genes.

Authors:  Edward Glasscock; Jing Qian; Jong W Yoo; Jeffrey L Noebels
Journal:  Nat Neurosci       Date:  2007-11-04       Impact factor: 24.884

6.  Risk alleles for multiple sclerosis identified by a genomewide study.

Authors:  David A Hafler; Alastair Compston; Stephen Sawcer; Eric S Lander; Mark J Daly; Philip L De Jager; Paul I W de Bakker; Stacey B Gabriel; Daniel B Mirel; Adrian J Ivinson; Margaret A Pericak-Vance; Simon G Gregory; John D Rioux; Jacob L McCauley; Jonathan L Haines; Lisa F Barcellos; Bruce Cree; Jorge R Oksenberg; Stephen L Hauser
Journal:  N Engl J Med       Date:  2007-07-29       Impact factor: 91.245

7.  Functional epistasis on a common MHC haplotype associated with multiple sclerosis.

Authors:  Jon W Gregersen; Kamil R Kranc; Xiayi Ke; Pia Svendsen; Lars S Madsen; Allan Randrup Thomsen; Lon R Cardon; John I Bell; Lars Fugger
Journal:  Nature       Date:  2006-09-27       Impact factor: 49.962

8.  The inheritance of resistance alleles in multiple sclerosis.

Authors:  Sreeram V Ramagopalan; Andrew P Morris; David A Dyment; Blanca M Herrera; Gabriele C DeLuca; Matthew R Lincoln; Sarah M Orton; Michael J Chao; A Dessa Sadovnick; George C Ebers
Journal:  PLoS Genet       Date:  2007-07-20       Impact factor: 5.917
  8 in total
  4 in total

Review 1.  Type 1 diabetes mellitus and multiple sclerosis: common etiological features.

Authors:  Adam E Handel; Lahiru Handunnetthi; George C Ebers; Sreeram V Ramagopalan
Journal:  Nat Rev Endocrinol       Date:  2009-11-03       Impact factor: 43.330

2.  HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain).

Authors:  Oscar Fernández; Alfredo R-Antigüedad; María Jesús Pinto-Medel; Mari Mar Mendibe; Nestor Acosta; Begoña Oliver; Miguel Guerrero; Marcos Papais-Alvarenga; Victoria Fernández-Sánchez; Laura Leyva
Journal:  J Neurol       Date:  2009-12       Impact factor: 4.849

3.  What is Next for the Genetics of Multiple Sclerosis?

Authors:  Sreeram V Ramagopalan; David A Dyment
Journal:  Autoimmune Dis       Date:  2011-03-28

4.  High Resolution Haplotype Analyses of Classical HLA Genes in Families With Multiple Sclerosis Highlights the Role of HLA-DP Alleles in Disease Susceptibility.

Authors:  Kazutoyo Osoegawa; Lisa E Creary; Gonzalo Montero-Martín; Kalyan C Mallempati; Sridevi Gangavarapu; Stacy J Caillier; Adam Santaniello; Noriko Isobe; Jill A Hollenbach; Stephen L Hauser; Jorge R Oksenberg; Marcelo A Fernández-Viňa
Journal:  Front Immunol       Date:  2021-05-25       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.